There are gene abnormalities in tumors, carcinogenesis driven by viral infections, and other mechanisms that contribute to inactivate p53 functions and its signaling outcomes (Scheffner et al., 1990; Camus et al., 2003; Rayburn et al., 2005). Here, TP53 is linked to viral infectious disease.